Editorial: Predicting outcome in patients with asymptomatic aortic stenosis

Circulation

Volumn 120, Issue 1, 2009, Pages 9-11

  Coglianese, Erin E ^a   Davidoff, Ravin ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

Author keywords

Editorials; Natriuretic peptides; Valves

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ANGINA PECTORIS; AORTA STENOSIS; AORTA VALVE REPLACEMENT; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; EDITORIAL; HEART FAILURE; HEART OUTPUT; HEART VENTRICLE FUNCTION; KIDNEY FAILURE; MORBIDITY; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SYMPTOM; SYNCOPE; AORTA VALVE STENOSIS; HOSPITALIZATION; HUMAN; NOTE; PREDICTION AND FORECASTING; RISK FACTOR;

AORTIC VALVE STENOSIS; HUMANS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 67651098686     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.875591     Document Type: Editorial

References (18)

1. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the Am College of Cardiology/Am Heart Association Task Force on Practice Guidelines (Writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006;114:e84-e231.
2. Otto CM. Valvular aortic stenosis: disease severity and timing of intervention. J Am Coll Cardiol. 2006;47:2141-2151.
3. Dal-Bianco JP, Khandheria BK, Mookadam F, Gentile F, Sengupta PP. Management of asymptomatic severe aortic stenosis. J Am Coll Cardiol. 2008;52:1279-1292.
4. Edwards FH, Peterson ED, Coombs LP, DeLong ER, Jamieson WR, Shroyer ALW, Grover FL. Prediction of operative mortality after valve replacement surgery. J Am Coll Cardiol. 2001;37:885-892.
5. Monin J-L, Lancellotii P, Monchi M, Lim P, Weiss E, Piérard L, Gueret P. Risk score for predicting outcome in patients with asymptomatic aortic stenosis. Circulation. 2009;120:69-75.
6. Rosenhek R, Klaar U, Schemper M, Scholten C, Heger M, Gabriel H, Binder T, Maurer G, Baumgartner H. Mild and moderate aortic stenosis: natural history and risk stratification by echocardiography. Eur Heart J. 2004;25:199-205.
7. Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG, Barnes ME, Tajik AJ. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation. 2005;111:3290-3295.
8. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, Maurer G, Baumgartner H. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med. 2000;343:611-617.
9. Feuchtner GM, Muller S, Grander W, Alber HF, Bartel T, Friedrich GJ, Reinthaler M, Pachinger O, zur Nedden D, Dichtl W. Aortic valve calcification as quantified with multislice computed tomography predicts short term clinical outcome in patients with asymptomatic aortic stenosis. J Heart Valve Dis. 2006;15:494-498.
10. Wachtell K. Left ventricular systolic performance in asymptomatic aortic stenosis. Eur Heart J. 2008;10(suppl):E16-E22.
11. Lim P, Monin J, Monchi M, Garot Jj, Pasquet A, Hittinger L, Vanoverschelde JL, Carayon A, Gueret P. Predictors of outcome in severe aortic stenosis and normal left ventricular function: role of B-type naturetic peptide. Eur Heart J. 2004;25:2048-2053.
12. Van Pelt NC, Kerr AJ, Legget ME, Pasupati S, Wahlley G, Wong S, Zeng I, Stewart RAH. Increased B-type natriuretic peptide is associated with an abnormal blood pressure response to exercise in asymptomatic aortic stenosis. Int J Cardiol. 2008;127:313-320.
13. Weber M, Arnold R, Rau M, Elsaesser A, Brandt R, Mitrovic V, Hamm C. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J. 2005;26:1023-1030.
14. Gerber IL, Legget ME, West TM, Richards AM, Stewart RAH. Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration. Am J Cardiol. 2005;95:898-901.
15. Johnson AM. Aortic stenosis, sudden cardiac death, and the left ventricular baroreceptors. Heart. 1971;33:1-5.
16. Mark AL, Kioschos M, Abboud FM, Heistad DD, Schmid PG. Abnormal vascular responses to exercise in patients with aortic stenosis. J Clin Invest. 1973;52:1138-1146.
17. Bergler-Klein J, Mundigler G, Pibarot P, Burwash IG, Dumesnil JG, Blais C, Fuchs C, Mohty D, Beanlands RS, Hachicha Z, Walter-Publig N, Rader F, Baumgartner H. B-type natriuretic peptide in low-flow, lowgradient aortic stenosis. Circulation. 2007;115:2848-2855.
18. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torraca L, Wenink A. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28:230-268.